Antithrombin is a naturally occurring protein that regulates blood coagulation. It is a potent anticoagulant that prevents the formation of blood clots, which can lead to life-threatening conditions such as stroke, heart attack, and pulmonary embolism. Antithrombin is used as a therapeutic agent in the treatment and prevention of thrombosis, a condition in which blood clots form in the blood vessels.
The global antithrombin market is growing at a steady rate, driven by the increasing prevalence of thrombosis and the rising demand for anticoagulant therapy. The market for antithrombin is segmented based on type, application, source, and region.
By type, the market is divided into human antithrombin and recombinant antithrombin. Human antithrombin is derived from human plasma and is used in the treatment of hereditary antithrombin deficiency, while recombinant antithrombin is produced using genetic engineering techniques and is used in the treatment of acquired antithrombin deficiency.
Read More:
https://cmitoc.blogspot.com/2023/02/the-increasing-cases-of-several-health.html
